We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATEN icon
1926
A10 Networks
ATEN
$2B
$195K ﹤0.01%
28,636
+6,909
+32% +$46.4K
AROW icon
1927
Arrow Financial
AROW
$725M
$195K ﹤0.01%
7,370
SIBN icon
1928
SI-BONE Inc
SIBN
$852M
$195K ﹤0.01%
12,210
+3,824
+46% +$60.3K
CMTL icon
1929
Comtech Telecommunications
CMTL
$52.1M
$194K ﹤0.01%
11,475
KBAL
1930
DELISTED
Kimball International
KBAL
$193K ﹤0.01%
16,738
SM icon
1931
SM Energy
SM
$7.71B
$193K ﹤0.01%
51,354
HY icon
1932
Hyster-Yale Materials Handling
HY
$614M
$192K ﹤0.01%
4,976
CELH icon
1933
Celsius Holdings
CELH
$6.99B
$192K ﹤0.01%
+49,017
New +$116K
PRTA icon
1934
Prothena Corp
PRTA
$475M
$192K ﹤0.01%
18,324
ATRS
1935
DELISTED
Antares Pharma, Inc.
ATRS
$191K ﹤0.01%
69,581
AMTB icon
1936
Amerant Bancorp
AMTB
$1.15B
$191K ﹤0.01%
12,722
+5,758
+83% +$77.6K
TGH
1937
DELISTED
Textainer Group Holdings limited
TGH
$191K ﹤0.01%
23,378
+1,299
+6% +$10.6K
PTGX icon
1938
Protagonist Therapeutics
PTGX
$9.84B
$191K ﹤0.01%
+10,796
New +$135K
MSGN
1939
DELISTED
MSG Networks Inc.
MSGN
$191K ﹤0.01%
19,156
BJRI icon
1940
BJ's Restaurants
BJRI
$1.48B
$190K ﹤0.01%
9,083
FCBC icon
1941
First Community Bankshares
FCBC
$927M
$190K ﹤0.01%
8,470
APEI icon
1942
American Public Education
APEI
$826M
$190K ﹤0.01%
6,422
NVEC icon
1943
NVE Corp
NVEC
$591M
$189K ﹤0.01%
3,063
+1,404
+85% +$80.2K
XENT
1944
DELISTED
Intersect ENT, Inc
XENT
$189K ﹤0.01%
13,971
CNDT icon
1945
Conduent
CNDT
$241M
$189K ﹤0.01%
79,131
+16,533
+26% +$38.4K
MEET
1946
DELISTED
The Meet Group, Inc. Common Stock
MEET
$189K ﹤0.01%
30,234
STEL
1947
DELISTED
Stellar Bancorp
STEL
$188K ﹤0.01%
8,948
PUMP icon
1948
ProPetro Holding
PUMP
$1.42B
$187K ﹤0.01%
36,472
WRLD icon
1949
World Acceptance Corp
WRLD
$884M
$187K ﹤0.01%
2,848
CPF icon
1950
Central Pacific Financial
CPF
$997M
$187K ﹤0.01%
11,636

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.